Ocumension (Hong Kong) Ltd.

Paediatric Ophthalmology

Ocumension (Hong Kong) Ltd. focuses on paediatric eye care, with clinical research centered on myopia in children and adolescents. The sponsor’s clinical activity reflects interest in conditions that affect visual development during childhood.

  • Myopia progression
  • Paediatric subjects
  • Vision development

The research portfolio is directed toward ophthalmic treatment areas relevant to early-life refractive disorders.

Refractive Error Management

The sponsor’s clinical interest includes refractive error control, particularly interventions aimed at slowing the worsening of short-sightedness. This places emphasis on maintaining visual function in growing patients.

  • Axial elongation
  • Visual acuity
  • Ophthalmic solutions

Its research activity is concentrated in therapeutic approaches used to manage the course of myopic progression.

Ocular Pharmacotherapy

Ocumension’s funded research involves ophthalmic pharmacology, with attention to topical treatments designed for long-term use in children. The sponsor’s work is aligned with drug-based management of chronic eye conditions.

  • Atropine sulfate
  • Topical ocular treatment
  • Safety and tolerability

This therapeutic area highlights interest in medications intended for sustained control of pediatric myopia.

Multicenter Clinical Ophthalmology

The sponsor supports research conducted across multiple clinical research sites and countries, indicating involvement in collaborative ophthalmic studies. The geographic spread of activity supports evaluation of eye treatments in diverse patient populations.

  • Multicenter studies
  • International recruitment
  • Cross-site ophthalmic research

Its clinical research landscape remains focused on vision-related therapy within a pediatric setting.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of Atropine Sulfate eye drops (0.

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Hungary Ireland Poland Slovakia Spain